Medium-term impact of the SARS-CoV-2 mRNA vaccine against disease activity in patients with systemic lupus erythematosus
暂无分享,去创建一个
Masao Tanaka | A. Morinobu | R. Hiwa | S. Akizuki | A. Onishi | K. Kitagori | R. Nakashima | H. Yoshifuji | M. Shirakashi | H. Tsuji | H. Onizawa | Tsuneyasu Yoshida | Y. Takase